The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines

por Majumdar, S, Diamandis, E P
Publicado 1999

Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer.

por Zarghami, N., Grass, L., Diamandis, E. P.
Publicado 1997

p53 protein is absent from the serum of patients with lung cancer.

por Levesque, M. A., D'Costa, M., Diamandis, E. P.
Publicado 1996

Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.

por Howarth, D. J., Aronson, I. B., Diamandis, E. P.
Publicado 1997

Codon 89 polymorphism in the human 5 α -reductase gene in primary breast cancer

por Scorilas, A, Bharaj, B, Giai, M, Diamandis, E P
Publicado 2001

Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer

por Scorilas, A, Kyriakopoulou, L, Katsaros, D, Diamandis, E P
Publicado 2001

Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer

por Sidiropoulos, M, Chang, A, Jung, K, Diamandis, E P
Publicado 2001

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects

por Shan, S J C, Scorilas, A, Katsaros, D, Diamandis, E P
Publicado 2007

Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library

por Luo, L-Y, Herrera, I, Soosaipillai, A, Diamandis, E P
Publicado 2002

Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.

por Levesque, M. A., Clark, G. M., Yu, H., Diamandis, E. P.
Publicado 1995

Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination

por Yu, H, Levesque, M A, Clark, G M, Diamandis, E P
Publicado 1999

Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue

por Luo, L-Y, Meyts, E Rajpert-De, Jung, K, Diamandis, E P
Publicado 2001

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance

por Luo, L-Y, Diamandis, E P, Look, M P, Soosaipillai, A P, Foekens, J A
Publicado 2002

Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues

por Nakamura, T, Scorilas, A, Stephan, C, Yousef, G M, Kristiansen, G, Jung, K, Diamandis, E P
Publicado 2003

Prostate-specific antigen in serum of women with breast cancer.

por Giai, M., Yu, H., Roagna, R., Ponzone, R., Katsaros, D., Levesque, M. A., Diamandis, E. P.
Publicado 1995

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer

por Chang, A, Yousef, G M, Scorilas, A, Grass, L, Sismondi, P, Ponzone, R, Diamandis, E P
Publicado 2002

Kallikrein gene downregulation in breast cancer

por Yousef, G M, Yacoub, G M, Polymeris, M-E, Popalis, C, Soosaipillai, A, Diamandis, E P
Publicado 2004

Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients.

por Zarghami, N., Giai, M., Yu, H., Roagna, R., Ponzone, R., Katsaros, D., Sismondi, P., Diamandis, E. P.
Publicado 1996

Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.

por Yu, H., Levesque, M. A., Khosravi, M. J., Papanastasiou-Diamandi, A., Clark, G. M., Diamandis, E. P.
Publicado 1996

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer

por Talieri, M, Li, L, Zheng, Y, Alexopoulou, D K, Soosaipillai, A, Scorilas, A, Xynopoulos, D, Diamandis, E P
Publicado 2009